Published in BMC Biochem on May 20, 2010
A spatial gradient coordinates cell size and mitotic entry in fission yeast. Nature (2009) 3.23
minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron (1995) 2.74
Polar gradients of the DYRK-family kinase Pom1 couple cell length with the cell cycle. Nature (2009) 2.67
Isolation of phosphorylated peptides and proteins on ion exchange papers. Anal Biochem (1978) 2.33
Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem (1998) 2.29
Rapid protein kinase assay using phosphocellulose-paper absorption. Anal Biochem (1975) 2.17
Specificity determinants of substrate recognition by the protein kinase DYRK1A. J Biol Chem (2000) 2.05
DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease. J Biol Chem (2007) 1.54
DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. Am J Hum Genet (2008) 1.45
Function and regulation of Dyrk1A: towards understanding Down syndrome. Cell Mol Life Sci (2009) 1.44
The C. elegans DYRK Kinase MBK-2 Marks Oocyte Proteins for Degradation in Response to Meiotic Maturation. Curr Biol (2005) 1.44
The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol Biol Cell (1998) 1.41
Label-free kinase profiling using phosphate affinity polyacrylamide gel electrophoresis. Mol Cell Proteomics (2006) 1.37
Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation. FEBS J (2009) 1.29
Mnb/Dyrk1A is transiently expressed and asymmetrically segregated in neural progenitor cells at the transition to neurogenic divisions. Dev Biol (2002) 1.28
Mirk/Dyrk1B in cancer. J Cell Biochem (2007) 1.25
The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications. J Neural Transm Suppl (2003) 1.25
Alternative splicing variants of dual specificity tyrosine phosphorylated and regulated kinase 1B exhibit distinct patterns of expression and functional properties. Biochem J (2003) 1.22
Role for DYRK family kinases on regulation of apoptosis. Biochem Pharmacol (2008) 1.14
A zebrafish screen for craniofacial mutants identifies wdr68 as a highly conserved gene required for endothelin-1 expression. BMC Dev Biol (2006) 1.13
A non-radioactive method for the assay of many serine/threonine-specific protein kinases. Biochem J (2002) 1.04
Quantitative methods for the analysis of protein phosphorylation in drug development. Expert Rev Proteomics (2004) 1.04
Up-regulation of sodium pump activity in Xenopus laevis oocytes by expression of heterologous beta 1 subunits of the sodium pump. Biochem J (1991) 1.02
DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy. J Biol Chem (2009) 1.00
DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A): a gene with dosage effect during development and neurogenesis. ScientificWorldJournal (2006) 1.00
The Yak1 kinase is involved in the initiation and maintenance of hyphal growth in Candida albicans. Mol Biol Cell (2008) 0.98
Current in vitro kinase assay technologies: the quest for a universal format. Curr Drug Discov Technol (2008) 0.94
A monoclonal antibody to the phosphorylated form of glial fibrillary acidic protein: application to a non-radioactive method for measuring protein kinase activities. Biochem Biophys Res Commun (1991) 0.91
Enzyme-linked immunosorbent assay for measurement of JNK, ERK, and p38 kinase activities. Biol Chem (1998) 0.86
Cooperation to amplify gene-dosage-imbalance effects. Trends Mol Med (2006) 0.84
Recent advances in technologies for analyzing protein kinases. J Pharmacol Sci (2007) 0.83
Enzyme-linked immunosorbent assay for the determination of p21-activated kinase activity. J Biochem (2001) 0.81
Development of solid-phase enzyme-linked immunosorbent assays for the determination of epidermal growth factor receptor and pp60c-src tyrosine protein kinase activity. Anal Biochem (1992) 0.81
A chemiluminescent microtiter plate assay for sensitive detection of protein kinase activity. Anal Biochem (1997) 0.79
Two dual specificity kinases are preferentially induced by wild-type rather than by oncogenic RAS-P21 in Xenopus oocytes. Front Biosci (2006) 0.76
Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation. FEBS J (2009) 1.29
Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich domain: phosphorylation by DYRK1A and colocalization with splicing factors. J Biol Chem (2003) 1.23
Alternative splicing variants of dual specificity tyrosine phosphorylated and regulated kinase 1B exhibit distinct patterns of expression and functional properties. Biochem J (2003) 1.22
Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines. FEBS J (2005) 1.21
Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/signal transducer and activator of transcription activation by receptor heterodimers. Mol Endocrinol (2002) 1.16
The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site. BMC Biochem (2006) 1.10
Transient expression of Mnb/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling. Development (2011) 1.08
DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression. Biochem Biophys Res Commun (2003) 1.08
A complex interaction pattern of CIS and SOCS2 with the leptin receptor. J Cell Sci (2006) 0.97
Unusual function of the activation loop in the protein kinase DYRK1A. Biochem Biophys Res Commun (2003) 0.91
Mechanism of dual specificity kinase activity of DYRK1A. FEBS J (2013) 0.89
Leptin induces inflammation-related genes in RINm5F insulinoma cells. BMC Mol Biol (2007) 0.89
Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activity. J Biol Chem (2010) 0.88
Characterization of cyclin L1 as an immobile component of the splicing factor compartment. FASEB J (2007) 0.86
Mechanism of attenuation of leptin signaling under chronic ligand stimulation. BMC Biochem (2010) 0.86
Characterization of the human DYRK1A promoter and its regulation by the transcription factor E2F1. BMC Mol Biol (2008) 0.86
DYRK1A: a potential drug target for multiple Down syndrome neuropathologies. CNS Neurol Disord Drug Targets (2014) 0.85
NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect. PLoS One (2013) 0.83
Effect of hyperinsulinemia and type 2 diabetes-like hyperglycemia on expression of hepatic cytochrome p450 and glutathione s-transferase isoforms in a New Zealand obese-derived mouse backcross population. J Pharmacol Exp Ther (2002) 0.83
Extracellular ATP activates NFAT-dependent gene expression in neuronal PC12 cells via P2X receptors. BMC Neurosci (2011) 0.79
Cloning and functional characterization of the ovine malic enzyme promoter. Gene (2008) 0.77
Site-selective tagging of proteins by pnictogen-mediated self-assembly. Chem Commun (Camb) (2017) 0.75